UNITED KINGDOM – Cambridge Epigenetix (CEGX), a life sciences tools and technology company that is revolutionizing genome sequencing, has announced the signing of a US$88 million Series D financing, bringing…
Read MoreCambridge Epigenetix secures US$ 88 million series D financing to enhance DNA sequence technology platform
